High concentrations of CA 125 in uterine flushings: Influence of cause of infertility and menstrual cycle day

Gynecological Endocrinology

Volumn 16, Issue 1, 2002, Pages 19-25

  Hamilton, J A ^a   Iles, R K ^a   Gunn, L K ^a   Wilson, C M Y ^a   Lower, A M ^a   Grudzinskas, J G ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

CA 125; Endometrial Proteins; Infertility; Uterine Flushings

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; FEMALE; FEMALE INFERTILITY; FOLLICULAR PHASE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SECRETION; RADIOIMMUNOASSAY; TRANSVAGINAL ECHOGRAPHY; UTERUS; UTERUS FLUID;

EID: 0036128152     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/gye.16.1.19.25     Document Type: Article

References (38)

1. Dating the endometrial biopsy
2. Human endometrial peptides: A review of their potential role in implantation and placentation
3. Blastocyst-endometrial interaction: An appraisal of some old and new ideas
4. Reactivity of a monoclonal antibody with human ovarian carcinoma
5. Multimodal approach to screening for ovarian cancer
6. Screening for ovarian cancer: A pilot randomised controlled trial
7. Ovarian cancer: Screening, treatment and follow-up
8. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125
9. The distribution of CA 125 in the reproductive tract of pregnant and non pregnant women
10. Cancer antigen CA 125 is produced by human endometrial stromal cells
11. CA-125 secretion by luteal endometrium in vitro
12. CA 125 is an excretory product of human endometrial glands
13. CA 125 and CA 19-9 immunolocalization in normal, hyperplastic and carcinomatous endometrium
14. Tumor marker CA-125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle
15. Alteration in levels of CA 125 during the menstrual cycle
16. Pronounced increases in the concentration of an ovarian tumour marker, CA-125, in serum of a healthy subject during menstruation
17. Serum CA-125 antigen levels increase during menses
18. Serum CA 125 levels during the menstrual cycle
19. The effect of the menstrual cycle on serum CA 125 levels: A population study
20. CA-125 levels in human uterine fluid
21. The measurement of CA 125 and placental protein 14 in uterine flushings in women with recurrent miscarriage; relation to endometrial morphology
22. Evaluation of serum CA 125 concentrations as predictors of pregnancy with human in vitro fertilization
23. Correlation of serum and follicular fluid concentrations of placental protein 14 and CA-125 in in vitro fertilization-embryo transfer patients
24. High CA-125 concentrations in peritoneal fluid of normal cyclic women with various infertility-related factors as demonstrated with two-step immunoradiometric assay
25. Elevated serum concentrations of CA-125 in patients with advanced endometriosis
26. Concentrations of placental protein 14 in uterine flushings from infertile women: Validation of the collection technique and method of expression of results
27. Measurement of protein using bicinchoninic acid
28. Cyclic variation in concentrations of protein and hexose in human endometrial flushings collected by an improved technique
29. Detection of ovarian cancer marker CA-125 in human seminal plasma
30. The tumor marker CA 125 is a common constituent of normal cervical mucus
31. CA-125 levels in cervical mucus during the menstrual cycle
32. Marker profile of mesothelial cells versus ovarian carcinoma cells
33. CA-125 serum concentrations during the menstrual cycle
34. Correlation between peripheral CA-125 levels and ovarian activity
35. Serum CA-125 levels do not depend on ovarian steroidogenesis
36. The use of biochemical markers in the diagnosis of endometriosis
37. Fluctuations in CA 125 and CA 15-3 serum concentrations during spontaneous ovulatory cycles